Starting treatment: latest news

Starting treatment resources

Starting treatment features

Starting treatment in your own words

Starting treatment news from aidsmap

More news

Starting treatment news selected from other sources

  • Four years with HIV and counting…

    Today marks my fourth anniversary, or annHIVersary if you will, of life with HIV. Those four years have really flown past, so what’s changed? What does the future hold?

    04 August 2015 | Beyond Positive
  • Stribild Superior to Boosted Atazanavir in Treatment-Naive Women

    Stribild proved virologically superior to atazanavir/ritonavir plus tenofovir/emtricitabine (TDF/FTC) at 48 weeks in WAVES, an international trial in 575 antiretroviral-naive women. No one in the Stribild arm had emergent resistance upon virologic failure, compared with 3 women in the atazanavir arm.

    27 July 2015 | NATAP
  • The Day the HIV Treatment Pendulum Stopped Swinging

    Normally at scientific conferences, even when study findings are considered to be major, a single researcher stands at a podium for 10 or 15 minutes, takes the audience on a guided PowerPoint tour of charts and graphs, receives a round of applause, and fields a few questions. Then the session moves on to its next topic. The presentation of the START findings was different.

    23 July 2015 | The Body Pro
  • IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

    Study also showed that most commonly used measure — CD4 count does not give accurate projection of illness risk.

    21 July 2015 | Science Speaks
  • NHS England announces annual investment decisions for certain specialised services [including HIV treatment as prevention]

    NHS England has today (2 July) set out its planned investment decisions for certain specialised services as part of its annual commissioning round.

    03 July 2015 | NHS England press release
  • START Making Sense

    The story of the START trial will continue to be told for a long time to come. For some it will be a tale of rigorous perseverance in the face of strong counter-prevailing headwinds and ultimate arrival at a result that is solid and conclusive. Others will see a single-minded and aggressive defense of a trial by investigators who refused to accept not only the obvious but also the evidence that rendered their design obsolete and even unethical.

    19 June 2015 | North Carolina AIDS Training and Education Center
  • More men test and treat early for HIV, but fear and stigma remain barriers

    Men who have recently tested positive for HIV are more comfortable with the idea of committing to a treatment regimen soon after diagnosis than they were a few years ago, suggest results presented in the latest HIV Seroconverstion Study Report, released today by the Kirby Institute at UNSW Australia.

    12 June 2015 | Kirby Institute
  • When to START has never been clearer

    Posirtive Lite editor Bob Leahy in conversation with CATIE’s Sean Hosein about START, the important and ground-breaking study that recently provided definitive evidence of the health benefits of starting HIV treatment sooner rather than later.

    10 June 2015 | Positive Lite
  • Gender difference in vital cell count of HIV patients

    Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster.

    10 June 2015 | Science Daily
  • Early HIV Treatment Is Essential, But So Is Testing And Linkage To Care

    Last week’s announcement of the Strategic Timing of AntiRetroviral Treatment (START) trial results confirms what many experts have long believed — early treatment for HIV reduces illness and death. While START further establishes the vital role of early antiretroviral therapy (ART), many questions remain on how to actually bring the life-saving benefits of treatment to individual patients.

    05 June 2015 | Health Affairs (blog)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.